Esophageal tissue engineering: Current status and perspectives

详细信息    查看全文

• 作者：T. Poghosyan^a ; ^b ; J. Catry^b ; ^c ; M. Luong-Nguyen^b ; ^c ; P. Bruneval^d ; T. Domet^b ; ^e ; L. Arakelian^b ; R. Sfeir^f ; L. Michaud^f ; V. Vanneaux^b ; ^e ; F. Gottrand^f ; J. Larghero^b ; ^e ; P. Cattan^b ; ^c ; ^{pierre.cattan@aphp.fr" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Tissue engineering ; Esophagus ; Bioengineering ; Absorbable scaffold
• 刊名：Journal of Visceral Surgery
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：153
• 期：1
• 页码：21-29
• 全文大小：1746 K

文摘

Tissue engineering, which consists of the combination and in vivo implantation of elements required for tissue remodeling toward a specific organ phenotype, could be an alternative for classical techniques of esophageal replacement. The current hybrid approach entails creation of an esophageal substitute composed of an acellular matrix and autologous epithelial and muscle cells provides the most successful results. Current research is based on the use of mesenchymal stem cells, whose potential for differentiation and proangioogenic, immune-modulator and anti-inflammatory properties are important assets. In the near future, esophageal substitutes could be constructed from acellular “intelligent matrices” that contain the molecules necessary for tissue regeneration; this should allow circumvention of the implantation step and still obtain standardized in vivo biological responses. At present, tissue engineering applications to esophageal replacement are limited to enlargement plasties with absorbable, non-cellular matrices. Nevertheless, the application of existing clinical techniques for replacement of other organs by tissue engineering in combination with a multiplication of translational research protocols for esophageal replacement in large animals should soon pave the way for health agencies to authorize clinical trials.